Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer (2022)
Attributed to:
Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2767-9764.crc-22-0298
PubMed Identifier: 36824220
Publication URI: http://europepmc.org/abstract/MED/36824220
Type: Journal Article/Review
Parent Publication: Cancer Research Communications
Issue: 11
ISSN: 2767-9764